- Seasoned Psychiatrist and Global Pharmaceutical R&D Executive with Over Two Decades of Experience in Clinical Development, Including at Eli…
An RSV vaccine could be a driver of blockbuster revenue....…
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...…
Johnson & Johnson stock rises Friday, still underperforms market...…
...
March 31 (Reuters) - A U.S. court on Friday declined to
delay......…
...(Reuters) - A U.S. court on Friday declined to delay......…
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Johnson & Johnson stock rises Thursday, still underperforms market...…
Johnson & Johnson stock rises Wednesday, still underperforms market...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
J&J lagged behind rival drugmakers Pfizer and GSK, both of which made major strides toward U.S. approval of their RSV…
...(Adds share price)
March 29 (Reuters) - Johnson & Johnson said......…
Zürich (www.aktiencheck.de) - Rating-Update:
Danielle Antalffy, Analyst der UBS, nimmt die Coverage der Aktie von Johnson & Johnson (J&J) (ISIN:…
...(Reuters) - Johnson & Johnson said it will discontinue the late......…
...(Adds background)
March 29 (Reuters) - Johnson & Johnson said......…
Johnson & Johnson stock falls Tuesday, underperforms market...…
read more...…
Amsterdam/Oslo – 28 March 2023 – MPC Energy Solutions (MPCES) invests in a 2.6 MW grid-tied combined-heat-and-power plant (CHP) development…
Johnson & Johnson stock rises Monday, outperforms market...…
These pharma giants beat the bear market last year....…
Johnson & Johnson stock rises Friday, outperforms market...…
read more...…
Johnson & Johnson stock rises Thursday, still underperforms market...…
"Concerning": Myocarditis Diagnoses Spiked In Military in 2021, New Data Show
…
Johnson & Johnson stock falls Wednesday, underperforms market...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Johnson & Johnson stock remains steady Tuesday, underperforms market...…
Even if we look at a longer time frame, AbbVie fares better, with its sales rising at an average annual…
Johnson & Johnson stock rises Monday, outperforms market...…
Johnson & Johnson, Toyota Motor, Infosys, Novartis and Equinix are part of the Zacks top Analyst Blog....…
Close to its 52-week low, this healthcare stalwart remains a good purchase....…
Johnson & Johnson stock falls Friday, still outperforms market...…
Todays Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Toyota Motor Corporation (TM)…
read more...…
Johnson & Johnson stock underperforms Thursday when compared to competitors...…
Johnson & Johnson stock outperforms market on strong trading day...…
Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts…
Johnson & Johnson stock rises Tuesday, still underperforms market...…
Johnson & Johnson stock underperforms Friday when compared to competitors despite daily gains...…
J&J, Novo Nordisk, AstraZeneca, Novartis and Sanofi have been highlighted in this Industry Outlook article....…
Kellogg, Johnson & Johnson, Crane, and BorgWarner are planning to hive off a chunk of their businesses in 2023. What…
Johnson & Johnson stock falls Thursday, still outperforms market...…
Johnson & Johnson stock falls Wednesday, underperforms market...…
NEW BRUNSWICK (dpa-AFX) - Der US-Pharma- und Konsumgüterkonzern Johnson & Johnson hat im Zusammenhang mit…
NEW BRUNSWICK (dpa-AFX) - Weniger verkaufte Covid-Impfungen und der starke Dollar haben den Pharma- und Konsumgüterkonzern…
BERLIN (dpa-AFX) - Ein besonders aussichtsreicher Impfstoffkandidat gegen die Immunschwächekrankheit Aids schützt nicht ausreichend vor einer…
NEW BRUNSWICK (dpa-AFX) - Der Gegenwind durch den starken US-Dollar hat den Gesundheitskonzern Johnson & Johnson…
NEW BRUNSWICK (dpa-AFX) - Der starke Dollar bremst den Gesundheitskonzern Johnson & Johnson . Für das…